Parecoxib Sodium is the first parenteral selective COX-2 inhibitor available for clinical use in pain management
Low-leveraged balance sheets, sizeable liquidity to keep credit profiles stable
JB Pharma reported 19% decrease in GHG intensity as compared to last year and commenced its journey of Scope 3 emissions
The products will be manufactured at the company's facility in Bengaluru
The company will develop and produce premixes for human nutrition applications
This exposé embarks on an illuminative journey, unfurling the crucial stratagems imperative for upholding public health, achieved through the unyielding fortress of pharmaceutical quality safeguards
Biocon Biologics recently acquired the global biosimilars business of its long-term partner Viatris
This collaboration marks a significant milestone in countering the disease burden by enhancing access to products for patients in the US
The inspection classification was determined by the agency as Voluntary Action Indicated
Amgen will be prohibited from leveraging its drug portfolio to disadvantage rivals and will be required to seek prior approval before acquiring related products
Subscribe To Our Newsletter & Stay Updated
